TARX (Tarsier Pharma) Total Liabilities: $7.32 Mil (As of Dec. 2025)


What is Tarsier Pharma Total Liabilities?

Tarsier Pharma TARX Total Liabilities is $7.32 Mil as of Dec. 2025.

Tarsier Pharma's Total Liabilities for the quarter that ended in Dec. 2025 was $7.32 Mil.

Tarsier Pharma's quarterly Total Liabilities declined from Dec. 2024 ($4.05 Mil) to Jun. 2025 ($3.71 Mil) but then increased from Jun. 2025 ($3.71 Mil) to Dec. 2025 ($7.32 Mil).

Tarsier Pharma's annual Total Liabilities increased from Dec. 2023 ($3.38 Mil) to Dec. 2024 ($4.05 Mil) and increased from Dec. 2024 ($4.05 Mil) to Dec. 2025 ($7.32 Mil).

Tarsier Pharma Total Liabilities Historical Data

* Premium members only.

The historical data trend for Tarsier Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsier Pharma Total Liabilities Chart

Tarsier Pharma Annual Data
Trend Dec23 Dec24 Dec25
Total Liabilities
3.38 4.05 7.32

Tarsier Pharma Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities 3.38 0.00 4.05 3.71 7.32

Tarsier Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tarsier Pharma's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.812+(0+6.504
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=7.32

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2.325--4.991
=7.32

Tarsier Pharma's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.812+(0+6.504
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=7.32

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=2.325--4.991
=7.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $7.32 Mil mean?
Tarsier Pharma (TARX) has a Total Liabilities of $7.32 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Tarsier Pharma and its competitors.
Is Tarsier Pharma's Total Liabilities too high?
Tarsier Pharma's current Total Liabilities is $7.32 Mil.
How does Tarsier Pharma's Total Liabilities compare to ?
Tarsier Pharma's Total Liabilities of $7.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Tarsier Pharma and its competitors. Tarsier Pharma's current Total Liabilities is $7.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsier Pharma stock overvalued right now?
Tarsier Pharma (TARX) has a current Total Liabilities of $7.32 Mil. The current Total Liabilities is $7.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Tarsier Pharma (TARX), the current Total Liabilities is $7.32 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tarsier Pharma Business Description

Comparable Companies
Tarsier Pharma Ltd is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet needs in ocular diseases with underlying inflammatory pathologies. Its dazdotuftide platform technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. The company's Product Candidate Pipeline includes TRS01 and TRS02.